Mechanisms of Action of Dimethyl Fumarate (Tecfidera) in Relapsing MS

Summary

This is a prospective study that will explore the mechanisms of efficacy of dimethyl fumarate (DMF) treatment in multiple sclerosis (MS). Investigators will enroll relapsing MS patients who are beginning therapy with DMF into a one-year longitudinal study in which blood and spinal fluid analyses, imaging and clinical studies will be performed to identify and measure changes associated with DMF therapy.

Timeline

Start

2016-04

Primary completion

2016-04

Completion

2016-04

Drugs

Indications